skip to Main Content

MD Anderson Cancer Center

Houston, Texas
0.000
Specialty
Oncology
Year
PGY2
Stipend
$60,000
OVERVIEW
Program
Residency
Accreditation
ASHP
Type of Residency
PGY2
Positions
4
Primary Specialty
Oncology
Length
1 years
Stipend
$60,000
Start Date
Preceptor
Andrea Landgraf Oholendt, Pharm.D., BCOP
RELATED CAREERS
Clinical Pharmacist
Oncology Pharmacist
Manager of Pharmacy Operations
Ambulatory Pediatric Oncology Pharmacist
Oncology Infusion Pharmacist
CONTACT INFORMATION
1515 Holcombe BlvdUnit 90, Houston, TX 77030
Andrea Landgraf Oholendt, PharmD, BCOP
DETAILED INFORMATION

Pharmacists completing the PGY2 Oncology Pharmacy Residency program at The University of Texas MD Anderson Cancer center will become competent and confident practitioners of oncology pharmacy practice. Residents will be accountable for achieving optimal drug therapy outcomes as an integral member of interdisciplinary health care teams while striving to improve the overall medication use process. They will exercise skill in oncology pharmacy operations, drug information, investigational pharmacy services, clinical research and writing, and providing education to health care professionals, patients, and the general public. Graduates from the program will be prepared to provide clinical pharmacy services for oncology, malignant hematology, and stem cell transplant patient populations in both the acute and ambulatory care settings.

Students Also Applied to

Back To Top